Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.59 USD | -3.02% | -13.13% | -53.35% |
05-15 | Cabaletta Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-22 | HC Wainwright Adjusts Cabaletta Bio's Price Target to $30 From $25, Maintains Buy Rating | MT |